SymBio Pharmaceuticals Limited (TYO:4582)
Japan · Delayed Price · Currency is JPY 87.00
0.00 (0.00%)
Feb 13, 2026, 3:30 PM JST
SymBio Pharmaceuticals Market Cap
SymBio Pharmaceuticals has a market cap or net worth of 5.17 billion as of February 13, 2026. Its market cap has decreased by -40.58% in one year.
Market Cap
5.17B
Enterprise Value
4.27B
Revenue
1.31B
Ranking
n/a
PE Ratio
n/a
Stock Price
87.00
Market Cap Chart
Since October 20, 2011, SymBio Pharmaceuticals's market cap has decreased from 7.08B to 5.17B, a decrease of -26.90%. That is a compound annual growth rate of -2.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 5.17B | 3.00% |
| Dec 30, 2025 | 5.02B | -44.92% |
| Dec 30, 2024 | 9.12B | -12.48% |
| Dec 29, 2023 | 10.42B | -58.97% |
| Dec 30, 2022 | 25.40B | -42.20% |
| Dec 30, 2021 | 43.94B | 203.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.19B |
| Pharma Foods International | 19.43B |
| Taiko Pharmaceutical | 14.97B |
| Wakamoto Pharmaceutical | 11.34B |
| Morishita Jintan | 9.31B |
| Solasia Pharma K.K. | 8.43B |
| MedRx | 6.83B |
| Cyfuse Biomedical K.K. | 6.75B |